Advances in infectious disease vaccine adjuvants

J Fan, S Jin, L Gilmartin, I Toth, WM Hussein… - Vaccines, 2022 - mdpi.com
Vaccines are one of the most significant medical interventions in the fight against infectious
diseases. Since their discovery by Edward Jenner in 1796, vaccines have reduced the …

Recent advances in intranasal liposomes for drug, gene, and vaccine delivery

VA Duong, TTL Nguyen, HJ Maeng - Pharmaceutics, 2023 - mdpi.com
Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles
produced from cholesterol and phospholipids. Recently, liposomes have been widely …

[HTML][HTML] Liposome-polymer complex for drug delivery system and vaccine stabilization

AK Umar, N Wathoni, JH Zothantluanga, S Das… - Heliyon, 2022 - Elsevier
Liposomes have been used extensively as micro-and nanocarriers for hydrophobic or
hydrophilic molecules. However, conventional liposomes are biodegradable and quickly …

Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways

T Darville - The Journal of infectious diseases, 2021 - academic.oup.com
Pelvic inflammatory disease (PID) results from ascension of sexually transmitted pathogens
from the lower genital tract to the uterus and/or fallopian tubes in women, with potential …

Update on the epidemiology, screening, and management of Chlamydia trachomatis infection

JS Hocking, WM Geisler, FYS Kong - Infectious Disease Clinics, 2023 - id.theclinics.com
Chlamydia trachomatis infection (“chlamydia”) is the most commonly diagnosed bacterial
sexually transmitted infection (STI) globally with an estimated 130 million new cases each …

[HTML][HTML] Swine as biomedical animal model for T-cell research—Success and potential for transmittable and non-transmittable human diseases

T Käser - Molecular immunology, 2021 - Elsevier
Swine is biologically one of the most relevant large animal models for biomedical research.
With its use as food animal that can be exploited as a free cell and tissue source for research …

[HTML][HTML] Chlamydia trachomatis: Cell biology, immunology and vaccination

SM Murray, PF McKay - Vaccine, 2021 - Elsevier
Chlamydia trachomatis is the causative agent of a highly prevalent sexually transmitted
bacterial disease and is associated with a number of severe disease complications. Current …

Vaccines, adjuvants and key factors for mucosal immune response

VA Correa, AI Portilho, E De Gaspari - Immunology, 2022 - Wiley Online Library
Vaccines are the most effective tool to control infectious diseases, which provoke significant
morbidity and mortality rates. Most vaccines are administered through the parenteral route …

Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe

D Gökengin, T Noori, A Alemany… - The Lancet Regional …, 2023 - thelancet.com
The current prevention efforts for STIs, HIV and viral hepatitis in the WHO European Region,
especially in the Central and Eastern subregions, are hindered by healthcare disparities …

Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy

D Christensen, C Polacek, DJ Sheward, L Hanke… - …, 2022 - thelancet.com
Background Licensed vaccines against SARS-CoV-2 effectively protect against severe
disease, but display incomplete protection against virus transmission. Mucosal vaccines …